Insulet
Insulet Corporation is a global medical device company dedicated to improving the lives of people with diabetes through innovative products like the Omnipod insulin management system. Founded in 2000, inspired by a father's determination to help his son, the company develops tubeless, wearable, Pod-based insulin delivery systems and other healthcare solutions. With a mission to simplify lives and a focus on sustainable growth, Insulet operates in 25 countries, serving over 500,000 customers worldwide. The company emphasizes innovation, quality manufacturing, and a strong commitment to diversity, equity, and inclusion.
Industries
Nr. of Employees
Very Large (1000+)
Patents
Devices and methods for initialization of drug delivery devices using measured analyte sensor information
US-12592306-B2
View DetailsAdjusting medicament delivery parameters in an open loop medicament delivery mode
US-12564679-B2
View Details
Devices and methods for initialization of drug delivery devices using measured analyte sensor information
US-12592306-B2
View DetailsAdjusting medicament delivery parameters in an open loop medicament delivery mode
US-12564679-B2
View DetailsProducts
Wearable tubeless disposable pod-based insulin delivery system
A disposable, wearable pod that provides continuous subcutaneous insulin delivery for multiple days without tubing or in-use needles.
Closed-loop automated insulin delivery system with cloud connectivity
Integrated system combining continuous glucose sensing inputs, control algorithms, and delivery hardware with cloud connectivity for remote management and data aggregation.
Mobile application for remote therapy management
Mobile software enabling remote interaction with delivery devices and user therapy management.
Wearable tubeless disposable pod-based insulin delivery system
A disposable, wearable pod that provides continuous subcutaneous insulin delivery for multiple days without tubing or in-use needles.
Closed-loop automated insulin delivery system with cloud connectivity
Integrated system combining continuous glucose sensing inputs, control algorithms, and delivery hardware with cloud connectivity for remote management and data aggregation.
Mobile application for remote therapy management
Mobile software enabling remote interaction with delivery devices and user therapy management.
Services
Customer care and product support services for users of wearable subcutaneous delivery systems.
Partnerships with researchers and clinical centers to run studies and collect real‑world data evaluating device performance and outcomes.
Independently operated, 24/7 multilingual hotline and online portal for anonymous reporting and corporate compliance inquiries.
Publication of sustainability reports and implementation of environmental and social strategies for product and operational impact reduction.
Customer care and product support services for users of wearable subcutaneous delivery systems.
Partnerships with researchers and clinical centers to run studies and collect real‑world data evaluating device performance and outcomes.
Independently operated, 24/7 multilingual hotline and online portal for anonymous reporting and corporate compliance inquiries.
Publication of sustainability reports and implementation of environmental and social strategies for product and operational impact reduction.
Expertise Areas
- Medical device development
- Automated insulin delivery systems
- Digital health and cloud-connected devices
- Clinical trials and real-world evidence generation
Key Technologies
- Wearable pod-based infusion devices
- Closed-loop AID control algorithms
- Cloud-based device connectivity
- Mobile health applications
News & Updates
Insulet exhibited and presented at the ATTD congress in Amsterdam, showcasing innovations like Omnipod 5.
Insulet hosted its first global community event in Amsterdam, bringing together people with diabetes from six markets.
Most prescribed automated insulin delivery system in the U.S. in 2024, based on claims data.
Omnipod is available in 25 countries worldwide.
Insulet exhibited and presented at the ATTD congress in Amsterdam, showcasing innovations like Omnipod 5.
Insulet hosted its first global community event in Amsterdam, bringing together people with diabetes from six markets.
Most prescribed automated insulin delivery system in the U.S. in 2024, based on claims data.
Omnipod is available in 25 countries worldwide.